Veterinary Medicines

FLIMABEND 100 MG/G SUSPENSION FOR USE IN DRINKING WATER FOR CHICKENS AND PIGS

Authorised
  • Flubendazole
Download as PDF

Product identification

Medicine name:
FLIMABEND 100 MG/G SUSPENSION FOR USE IN DRINKING WATER FOR CHICKENS AND PIGS
Flimabend 100 mg/ml Zawiesina do podania w wodzie do picia
Active substance:
  • Flubendazole
Target species:
  • Chicken (broiler)
  • Pig
  • Chicken
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Flubendazole
    100.00
    milligram(s)
    /
    1.00
    gram(s)
Pharmaceutical form:
  • Oral suspension
Withdrawal period by route of administration:
  • Oral use
    • Chicken (broiler)
      • Meat and offal
        2
        day
    • Pig
      • Meat and offal
        3
        day
      • Meat and offal
        4
        day
    • Chicken
      • Eggs
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP52AC12
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Poland
Available in:
  • Poland
Package description:
  • Cardboard box containing 2 sachets of 20 g suspension for use in drinking water
  • Cardboard box containing 6 containers of 750 g suspension for use in drinking water
  • Cardboard box containing 4 containers of 750 g suspension for use in drinking water
  • Cardboard box containing 25 sachets of 100 g suspension for use in drinking water
  • Cardboard box containing 5 sachets of 100 g suspension for use in drinking water
  • Cardboard box containing 1 sachet of 100 g suspension for use in drinking water
  • Cardboard box containing 24 sachets of 50 g suspension for use in drinking water
  • Cardboard box containing 2 sachets of 50 g suspension for use in drinking water
  • Cardboard box containing 24 sachets of 20 g suspension for use in drinking water

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Hybrid application (Article 13(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • KRKA tovarna zdravil d.d. Novo mesto
Marketing authorisation date:
Manufacturing sites for batch release:
  • TAD Pharma GmbH
  • KRKA tovarna zdravil d.d. Novo mesto
Responsible authority:
  • Office For Registration Of Medicinal Products Medical Devices And Biocidal Products
Authorisation number:
  • 2281
Date of authorisation status change:
Reference member state:
  • France
Procedure number:
  • FR/V/0242/001
Concerned member states:
  • Austria
  • Belgium
  • Bulgaria
  • Czechia
  • Denmark
  • Estonia
  • Germany
  • Greece
  • Hungary
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Polish (PDF)
Published on: 14/11/2024
Download

Labelling

This document does not exist in this language (English). You can find it in another language below.
Polish (PDF)
Published on: 14/11/2024
Download

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Polish (PDF)
Published on: 14/11/2024
Download